AnaptysBio, Inc. (ANAB)

46.10 +0.42 (+0.92%) USD  |  NASDAQ  |  Jan 20, 09:47
More

AnaptysBio Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade